Cerecin Joins NIHR HealthTech Research Centre in Brain Health as an Industry Partner

DENVER, Aug. 27, 2025 /PRNewswire/ — Cerecin, a global biotech company focused on neurometabolism, is proud to announce its partnership with the NIHR HealthTech Research Centre (HRC) in Brain Health. This collaboration sees Cerecin joining forces with industry leaders like GE Healthcare, Novo Nordisk, Roche Diagnostics, and Camtech Innovations. The HRC, located at King’s College London and the South London and Maudsley NHS Foundation Trust, is committed to pushing the boundaries in dementia care through innovative technologies. By employing brain scanning, blood sampling, computerized testing, and digital tools, the Centre aims to enhance the accuracy and timeliness of dementia diagnoses, ultimately reducing its societal burden.